Published in Adv Psychosom Med on April 19, 2011
Placebo-induced analgesia in an operant pain model in rats. Pain (2012) 1.55
"Liking" and "wanting" linked to Reward Deficiency Syndrome (RDS): hypothesizing differential responsivity in brain reward circuitry. Curr Pharm Des (2012) 1.31
Mindfulness-based relapse prevention for substance craving. Addict Behav (2012) 1.21
Neurogenetics and Nutrigenomics of Neuro-Nutrient Therapy for Reward Deficiency Syndrome (RDS): Clinical Ramifications as a Function of Molecular Neurobiological Mechanisms. J Addict Res Ther (2012) 1.19
Psychological processing in chronic pain: a neural systems approach. Neurosci Biobehav Rev (2013) 1.19
Exercise as a novel treatment for drug addiction: a neurobiological and stage-dependent hypothesis. Neurosci Biobehav Rev (2013) 1.10
Pain and suicidality: insights from reward and addiction neuroscience. Prog Neurobiol (2013) 1.08
Personalized medicine and opioid analgesic prescribing for chronic pain: opportunities and challenges. J Pain (2013) 1.06
Generational association studies of dopaminergic genes in reward deficiency syndrome (RDS) subjects: selecting appropriate phenotypes for reward dependence behaviors. Int J Environ Res Public Health (2011) 1.01
Marijuana: current concepts(†). Front Public Health (2013) 0.95
Retraining the addicted brain: a review of hypothesized neurobiological mechanisms of mindfulness-based relapse prevention. Psychol Addict Behav (2012) 0.95
Reward, interrupted: Inhibitory control and its relevance to addictions. Neuropharmacology (2013) 0.94
Brain-derived neurotrophic factor-estrogen interactions in the hippocampal mossy fiber pathway: implications for normal brain function and disease. Neuroscience (2012) 0.94
The phosphodiesterase-4 (PDE4) inhibitor rolipram decreases ethanol seeking and consumption in alcohol-preferring Fawn-Hooded rats. Alcohol Clin Exp Res (2012) 0.94
Activation of physiological stress responses by a natural reward: Novel vs. repeated sucrose intake. Physiol Behav (2015) 0.93
Synthetic cathinones and their rewarding and reinforcing effects in rodents. Adv Neurosci (Hindawi) (2014) 0.90
Functional homomers and heteromers of dopamine D2L and D3 receptors co-exist at the cell surface. J Biol Chem (2012) 0.87
Voxel-level comparison of arterial spin-labeled perfusion magnetic resonance imaging in adolescents with internet gaming addiction. Behav Brain Funct (2013) 0.86
Dopamine Genetics and Function in Food and Substance Abuse. J Genet Syndr Gene Ther (2013) 0.84
Noradrenergic β-receptor antagonism within the central nucleus of the amygdala or bed nucleus of the stria terminalis attenuates the negative/anxiogenic effects of cocaine. J Neurosci (2014) 0.84
Analysis of morphine responses in mice reveals a QTL on Chromosome 7. F1000Res (2016) 0.84
Integrating optogenetic and pharmacological approaches to study neural circuit function: current applications and future directions. Pharmacol Rev (2013) 0.83
Dissociable effects of CB1 receptor blockade on anxiety-like and consummatory behaviors in the novelty-induced hypophagia test in mice. Psychopharmacology (Berl) (2013) 0.83
Long-term changes in reward-seeking following morphine withdrawal are associated with altered N-methyl-D-aspartate receptor 1 splice variants in the amygdala. Neuroscience (2012) 0.82
The Molecular Neurobiology of Twelve Steps Program & Fellowship: Connecting the Dots for Recovery. J Reward Defic Syndr (2015) 0.81
Advances in genetic studies of substance abuse in China. Shanghai Arch Psychiatry (2013) 0.81
Release of endogenous cannabinoids from ventral tegmental area dopamine neurons and the modulation of synaptic processes. Prog Neuropsychopharmacol Biol Psychiatry (2014) 0.81
The effects of the preferential dopamine D(3) receptor antagonist S33138 on ethanol binge drinking in C57BL/6J mice. Synapse (2012) 0.80
Cav1.2 and Cav1.3 L-type calcium channels regulate dopaminergic firing activity in the mouse ventral tegmental area. J Neurophysiol (2014) 0.80
Learning and generalization from reward and punishment in opioid addiction. Behav Brain Res (2016) 0.79
Behavioral and electrophysiological effects of endocannabinoid and dopaminergic systems on salient stimuli. Front Behav Neurosci (2014) 0.79
Genetic risk for nicotine dependence in the cholinergic system and activation of the brain reward system in healthy adolescents. Neuropsychopharmacology (2013) 0.79
Exercise-based treatments for substance use disorders: evidence, theory, and practicality. Am J Drug Alcohol Abuse (2014) 0.79
Clinically Combating Reward Deficiency Syndrome (RDS) with Dopamine Agonist Therapy as a Paradigm Shift: Dopamine for Dinner? Mol Neurobiol (2015) 0.78
The selective D₃ receptor antagonist SB-277011A attenuates morphine-triggered reactivation of expression of cocaine-induced conditioned place preference. Synapse (2013) 0.78
Effects of nicotine deprivation and replacement on BOLD-fMRI response to smoking cues as a function of DRD4 VNTR genotype. Nicotine Tob Res (2014) 0.78
Some molecular mechanisms of dopaminergic and glutamatergic dysfunctioning in Parkinson's disease. J Neural Transm (Vienna) (2012) 0.78
Dynamic downregulation of Nogo receptor expression in the rat forebrain by amphetamine. Neurochem Int (2013) 0.78
Cocaine-induced locomotor sensitization in rats correlates with nucleus accumbens activity on manganese-enhanced MRI. NMR Biomed (2015) 0.77
Challenges in translational research: the views of addiction scientists. PLoS One (2014) 0.77
Hippocampal volume mediates the relationship between measures of pre-treatment cocaine use and within-treatment cocaine abstinence. Drug Alcohol Depend (2014) 0.77
Morphine disinhibits glutamatergic input to VTA dopamine neurons and promotes dopamine neuron excitation. Elife (2015) 0.76
Adolescent Social Isolation as a Model of Heightened Vulnerability to Comorbid Alcoholism and Anxiety Disorders. Alcohol Clin Exp Res (2016) 0.76
Cocaine withdrawal causes delayed dysregulation of stress genes in the hippocampus. PLoS One (2012) 0.76
Comorbid Cannabis and Tobacco Use in Adolescents and Adults. Curr Addict Rep (2016) 0.76
Can Genetic Testing Coupled with Enhanced Dopaminergic Activation Reduce Recidivism Rates in the Workers Compensation Legacy Cases? J Alcohol Drug Depend (2014) 0.75
Introduction to the special issue "Pharmacotherapies for the treatment of alcohol abuse and dependence" and a summary of patents targeting other neurotransmitter systems. Recent Pat CNS Drug Discov (2012) 0.75
Dopamine in the Brain: Hypothesizing Surfeit or Deficit Links to Reward and Addiction. J Reward Defic Syndr (2015) 0.75
Neurobiology of hedonic tone: the relationship between treatment-resistant depression, attention-deficit hyperactivity disorder, and substance abuse. Neuropsychiatr Dis Treat (2016) 0.75
Binge-like eating attenuates nisoxetine feeding suppression, stress activation, and brain norepinephrine activity. PLoS One (2014) 0.75
Independent and Interactive Effects of OPRM1 and DAT1 Polymorphisms on Alcohol Consumption and Subjective Responses in Social Drinkers. Alcohol Clin Exp Res (2017) 0.75
Pain mechanisms: a new theory. Science (1965) 24.47
Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study. JAMA (1990) 17.70
Neural systems of reinforcement for drug addiction: from actions to habits to compulsion. Nat Neurosci (2005) 16.18
Dopamine, learning and motivation. Nat Rev Neurosci (2004) 11.97
The reinstatement model of drug relapse: history, methodology and major findings. Psychopharmacology (Berl) (2002) 9.90
Drug addiction, dysregulation of reward, and allostasis. Neuropsychopharmacology (2001) 9.25
Lifetime co-occurrence of DSM-III-R alcohol abuse and dependence with other psychiatric disorders in the National Comorbidity Survey. Arch Gen Psychiatry (1997) 8.01
A MEDICAL TREATMENT FOR DIACETYLMORPHINE (HEROIN) ADDICTION. A CLINICAL TRIAL WITH METHADONE HYDROCHLORIDE. JAMA (1965) 7.83
Nucleus accumbens D2/3 receptors predict trait impulsivity and cocaine reinforcement. Science (2007) 6.75
Positive reinforcement produced by electrical stimulation of septal area and other regions of rat brain. J Comp Physiol Psychol (1954) 6.65
A cognitive model of drug urges and drug-use behavior: role of automatic and nonautomatic processes. Psychol Rev (1990) 6.46
Striatonigrostriatal pathways in primates form an ascending spiral from the shell to the dorsolateral striatum. J Neurosci (2000) 6.02
The glutamate homeostasis hypothesis of addiction. Nat Rev Neurosci (2009) 5.97
Cocaine cues and dopamine in dorsal striatum: mechanism of craving in cocaine addiction. J Neurosci (2006) 5.69
Dissociating the role of the orbitofrontal cortex and the striatum in the computation of goal values and prediction errors. J Neurosci (2008) 5.64
Neuroadaptation. Incubation of cocaine craving after withdrawal. Nature (2001) 5.14
Allelic association of human dopamine D2 receptor gene in alcoholism. JAMA (1990) 5.04
Behavioral phenotypes of inbred mouse strains: implications and recommendations for molecular studies. Psychopharmacology (Berl) (1997) 5.03
Cue-induced cocaine craving: neuroanatomical specificity for drug users and drug stimuli. Am J Psychiatry (2000) 4.87
Review. Neural mechanisms underlying the vulnerability to develop compulsive drug-seeking habits and addiction. Philos Trans R Soc Lond B Biol Sci (2008) 4.85
Anticraving medications for relapse prevention: a possible new class of psychoactive medications. Am J Psychiatry (2005) 4.80
Measuring reward with the conditioned place preference (CPP) paradigm: update of the last decade. Addict Biol (2007) 4.78
High impulsivity predicts the switch to compulsive cocaine-taking. Science (2008) 4.76
Addiction is a brain disease, and it matters. Science (1997) 4.68
An opponent-process theory of motivation. I. Temporal dynamics of affect. Psychol Rev (1974) 4.65
Drugs of abuse: anatomy, pharmacology and function of reward pathways. Trends Pharmacol Sci (1992) 4.57
Neurobiology of relapse to heroin and cocaine seeking: a review. Pharmacol Rev (2002) 4.23
Toward a model of drug relapse: an assessment of the validity of the reinstatement procedure. Psychopharmacology (Berl) (2006) 4.23
Social dominance in monkeys: dopamine D2 receptors and cocaine self-administration. Nat Neurosci (2002) 3.89
Cannabinoid and heroin activation of mesolimbic dopamine transmission by a common mu1 opioid receptor mechanism. Science (1997) 3.77
Measuring reward with the conditioned place preference paradigm: a comprehensive review of drug effects, recent progress and new issues. Prog Neurobiol (1998) 3.70
Conditioning factors in drug abuse: can they explain compulsion? J Psychopharmacol (1998) 3.65
Dopamine and drug addiction: the nucleus accumbens shell connection. Neuropharmacology (2004) 3.52
Long-term depression in the nucleus accumbens: a neural correlate of behavioral sensitization to cocaine. Nat Neurosci (2001) 3.41
The neuropsychological basis of addictive behaviour. Brain Res Brain Res Rev (2001) 3.33
Time-dependent increases in brain-derived neurotrophic factor protein levels within the mesolimbic dopamine system after withdrawal from cocaine: implications for incubation of cocaine craving. J Neurosci (2003) 3.30
Dramatic decreases in brain reward function during nicotine withdrawal. Nature (1998) 3.21
A key role for corticotropin-releasing factor in alcohol dependence. Trends Neurosci (2007) 3.16
Corticotropin-releasing factor within the central nucleus of the amygdala mediates enhanced ethanol self-administration in withdrawn, ethanol-dependent rats. J Neurosci (2006) 3.13
Personality and risk-taking: common biosocial factors. J Pers (2000) 3.13
PET imaging of dopamine D2 receptors during chronic cocaine self-administration in monkeys. Nat Neurosci (2006) 3.13
Animal models of alcoholism: neurobiology of high alcohol-drinking behavior in rodents. Crit Rev Neurobiol (1998) 3.07
The neurocircuitry of impaired insight in drug addiction. Trends Cogn Sci (2009) 3.01
Relapse to cocaine-seeking after hippocampal theta burst stimulation. Science (2001) 2.97
Neurobiological mechanisms in the transition from drug use to drug dependence. Neurosci Biobehav Rev (2004) 2.97
Review. Neurobiological mechanisms for opponent motivational processes in addiction. Philos Trans R Soc Lond B Biol Sci (2008) 2.97
Central amygdala ERK signaling pathway is critical to incubation of cocaine craving. Nat Neurosci (2005) 2.90
Personality and substance use disorders: a prospective study. J Consult Clin Psychol (2000) 2.86
Neuronal activity in monkey ventral striatum related to the expectation of reward. J Neurosci (1992) 2.86
Repeated cocaine exposure in vivo facilitates LTP induction in midbrain dopamine neurons. Nature (2005) 2.84
Influence of reward delays on responses of dopamine neurons. J Neurosci (2008) 2.78
Striatal dopamine d2/d3 receptor availability is reduced in methamphetamine dependence and is linked to impulsivity. J Neurosci (2009) 2.78
Genes and addiction. Nat Genet (2000) 2.75
Corticotropin-releasing factor 1 antagonists selectively reduce ethanol self-administration in ethanol-dependent rats. Biol Psychiatry (2006) 2.70
Fluctuations in nucleus accumbens dopamine concentration during intravenous cocaine self-administration in rats. Psychopharmacology (Berl) (1995) 2.60
Myths about the treatment of addiction. Lancet (1996) 2.58
Reward deficiency syndrome: genetic aspects of behavioral disorders. Prog Brain Res (2000) 2.58
Central catecholamine neuron systems: anatomy and physiology of the norepinephrine and epinephrine systems. Annu Rev Neurosci (1979) 2.51
New perspectives in basal forebrain organization of special relevance for neuropsychiatric disorders: the striatopallidal, amygdaloid, and corticopetal components of substantia innominata. Neuroscience (1988) 2.50
Prediction of reinforcing responses to psychostimulants in humans by brain dopamine D2 receptor levels. Am J Psychiatry (1999) 2.49
Rapid strengthening of thalamo-amygdala synapses mediates cue-reward learning. Nature (2008) 2.47
Postcocaine anhedonia. An animal model of cocaine withdrawal. Neuropsychopharmacology (1991) 2.41
Profound decreases in dopamine release in striatum in detoxified alcoholics: possible orbitofrontal involvement. J Neurosci (2007) 2.38
Localization of brain reinforcement mechanisms: intracranial self-administration and intracranial place-conditioning studies. Behav Brain Res (1999) 2.26
Bupropion is a nicotinic antagonist. J Pharmacol Exp Ther (2000) 2.26
Cue reactivity and cue reactivity interventions in drug dependence. NIDA Res Monogr (1993) 2.23
The opponent-process theory of acquired motivation: the costs of pleasure and the benefits of pain. Am Psychol (1980) 2.21
Glutamate transmission in addiction. Neuropharmacology (2008) 2.19
Brain stress systems in the amygdala and addiction. Brain Res (2009) 2.14
Suppression of ethanol-reinforced behavior by naltrexone is associated with attenuation of the ethanol-induced increase in dialysate dopamine levels in the nucleus accumbens. J Neurosci (1998) 2.12
Endocannabinoid signaling system and brain reward: emphasis on dopamine. Pharmacol Biochem Behav (2005) 2.05
Transition to addiction is associated with a persistent impairment in synaptic plasticity. Science (2010) 2.04
CRF-CRF1 system activation mediates withdrawal-induced increases in nicotine self-administration in nicotine-dependent rats. Proc Natl Acad Sci U S A (2007) 2.01
Decreased brain reward produced by ethanol withdrawal. Proc Natl Acad Sci U S A (1995) 2.00
The D2 dopamine receptor gene as a determinant of reward deficiency syndrome. J R Soc Med (1996) 1.98
Drug addiction: bad habits add up. Nature (1999) 1.97
Pathways to relapse: the neurobiology of drug- and stress-induced relapse to drug-taking. J Psychiatry Neurosci (2000) 1.96
Dopamine D3 receptor antagonism inhibits cocaine-seeking and cocaine-enhanced brain reward in rats. J Neurosci (2002) 1.84
Hypothalamic substrates of reward. Physiol Rev (1962) 1.84
Cannabinoid CB1 receptor antagonists as promising new medications for drug dependence. J Pharmacol Exp Ther (2004) 1.83
Limbic-striatal memory systems and drug addiction. Neurobiol Learn Mem (2002) 1.82
Quantitative trait loci mapping of three loci controlling morphine preference using inbred mouse strains. Nat Genet (1994) 1.82
The role of central dopamine D3 receptors in drug addiction: a review of pharmacological evidence. Brain Res Brain Res Rev (2005) 1.80
Adaptive increase in D3 dopamine receptors in the brain reward circuits of human cocaine fatalities. J Neurosci (1996) 1.78
Corticosterone levels determine individual vulnerability to amphetamine self-administration. Proc Natl Acad Sci U S A (1991) 1.76
The role of CRF and CRF-related peptides in the dark side of addiction. Brain Res (2009) 1.74
Complete and prolonged suppression of symptoms and consequences of alcohol-dependence using high-dose baclofen: a self-case report of a physician. Alcohol Alcohol (2004) 1.72
Modulation of hippocampus-dependent learning and synaptic plasticity by nicotine. Mol Neurobiol (2008) 1.71
mu-Opioid receptor knockout mice do not self-administer alcohol. J Pharmacol Exp Ther (2000) 1.67
Metabotropic glutamate receptor ligands as potential therapeutics for addiction. Curr Drug Abuse Rev (2009) 1.66
Cocaine-induced neuroadaptations in glutamate transmission: potential therapeutic targets for craving and addiction. Ann N Y Acad Sci (2010) 1.64
Dependence-induced increases in ethanol self-administration in mice are blocked by the CRF1 receptor antagonist antalarmin and by CRF1 receptor knockout. Pharmacol Biochem Behav (2007) 1.63
Critical assessment of how to study addiction and its treatment: human and non-human animal models. Pharmacol Ther (2005) 1.59
Glutamate and reinstatement. Curr Opin Pharmacol (2009) 1.59
A single in vivo exposure to cocaine abolishes endocannabinoid-mediated long-term depression in the nucleus accumbens. J Neurosci (2004) 1.57
Progression of changes in dopamine transporter binding site density as a result of cocaine self-administration in rhesus monkeys. J Neurosci (2001) 1.57
Brain DA D2 receptors predict reinforcing effects of stimulants in humans: replication study. Synapse (2002) 1.56
Allostasis and dysregulation of corticotropin-releasing factor and neuropeptide Y systems: implications for the development of alcoholism. Pharmacol Biochem Behav (2004) 1.56